• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 491/22 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or in which the condensed system contains four or more hetero rings

Patent holdings for IPC class C07D 491/22

Total number of patents in this class: 1203

10-year publication summary

46
50
51
71
71
105
116
144
147
104
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
383
37
Gilead Sciences, Inc.
2222
23
Idemitsu Kosan Co., Ltd.
4235
21
Hangzhou Adcoris Biopharma Co., Ltd.
33
19
Merck Sharp & Dohme LLC
3734
16
Merck Patent GmbH
5728
14
LG Chem, Ltd.
17921
13
Minghui Pharmaceutical (Hangzhou) Limited
44
13
Minghui Pharmaceutical (Shanghai) Limited
45
13
Nuvalent, Inc.
89
13
Immunomedics, Inc.
239
11
Shanghai Qilu Pharmaceutical Research and Development Centre Ltd.
112
10
Daiichi Sankyo Company, Limited
1890
9
Promega Corporation
589
9
Shanghai Hengrui Pharmaceutical Co., Ltd.
712
9
Pinotbio, Inc.
49
9
ScinoPharm Taiwan, Ltd.
129
8
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
873
8
Shionogi & Co., Ltd.
880
8
Abbvie Inc.
1836
7
Other owners 933